ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
3.650
+0.200 (5.80%)
Sep 26, 2025, 4:00 PM EDT - Market closed
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $410.62 million as of September 26, 2025. Its market cap has increased by 44.51% in one year.
Market Cap
410.62M
Enterprise Value
596.83M
1-Year Change
44.51%
Ranking
Category
Stock Price
$3.65
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $410.62M, a decrease of -79.90%. That is a compound annual growth rate of -25.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 410.62M | 113.41% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | 2.48B | 21.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |